Lighthouse IP Partners with IPDataLab to Deliver High Value Metadata Linking Patent Records to US‐FDA Approved Chemical and Biological Drug Information
Minneapolis, MN, Jan. 31, 2022 – The two companies are coming together to meet market demand for a streamlined path for integrating both common and uncommon drug approval information into existing patent data systems.
Recognizing an increase in the value of a patent is as simple as discovering a new link to corresponding commercial activity. Our focus is these links.
Who we areOffering data collections that are not widely available, our bulk data services can be easily integrated into any application, while our
web based search platform provides quick access to the data for individual users.
This data set covers biological drugs approved by the US-FDA and the patents linked to each drug. Each linkage is enriched with a set of additional high value data elements.
Dataset details
This data set covers chemical drugs approved by the US-FDA and the patents linked to each drug.
This data set covers most all standard authorities and links patents that have been declared essential to the associated standards.Each linkage is enriched with a set of additional high value data elements.
Dataset details
This data set is a full text document collection. Included are full text copies of most every U.S. Office Action – both back file and updates.
This data set contains an extraction of cited references and corresponding reasons for rejection derived from the text content of U.S. Office Actions. Each citation is enriched with a set of additional high value data elements.
Dataset details
IPDataLab is available to consult and collaborate with anyone that wants to build something cool and useful. We work with large and small companies and startups that need help reaching a broader market.
EXPLORE PArtnerships
Let us show you what is possible with leading edge intellectual property data intelligence.
Get In Touch